Determination of the high resolution structure of the polypeptide chain in amyloid fibrils

Lead Research Organisation: University of Edinburgh
Department Name: Sch of Physics and Astronomy

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Amyloid fibrils are highly organised filamentous structures formed by the self-assembly of polypeptides, and in vivo they are implicated in a number of diseases including Alzheimer¿s Disease and type II diabetes. Despite the fact that many different chemically unrelated proteins form amyloid fibrils, the final fibrillar complexes appear to share similar fundamental structures. The primary objective of the proposed work is to determine the intermolecular organisation of polypeptide in a model amyloid fibril system at high resolution using solid-state NMR techniques. Our model system is an 11-amino acid peptide that readily self-assembles, and we have already had great success in determining the high resolution structure of the individual peptides in their fibrillar form. All that remains is to determine the three-dimensional organisation of the peptides in a fibrillar array. The experimental data will be combined with molecular dynamics simulations to confirm and predict intermolecular constraints, and using this combination of experimental and theoretical approaches we will build up the first high-resolution structure of a system that to date has remained intractable. The second objective of the proposal is to extend the knowledge and methodological experience gained from this model polypeptide system to a significantly larger protein of 84 amino acids, the SH3 domain of the p85a subunit of phosphatidyl-inositol-3 kinase. Such a protein is larger than any system measured by solid-state NMR techniques to date and thus represents a significant challenge. In the first instance, we propose to determine the complete sequence assignments for this protein, an essential first step towards the determination of a structure, and a goal achievable within the lifetime of the proposed project. All of these approaches will provide us with insight into a type of quaternary structure that has singular relevance to a wide range of degenerative diseases.

Publications

10 25 50

publication icon
Cole HL (2010) Characterizing early aggregates formed by an amyloidogenic peptide by mass spectrometry. in Angewandte Chemie (International ed. in English)

publication icon
Debelouchina GT (2013) Higher order amyloid fibril structure by MAS NMR and DNP spectroscopy. in Journal of the American Chemical Society

publication icon
Fitzpatrick AW (2013) Atomic structure and hierarchical assembly of a cross-ß amyloid fibril. in Proceedings of the National Academy of Sciences of the United States of America

 
Description Amyloid fibrils are highly organised filamentous structures formed by the self-assembly of polypeptides, and in vivo they are implicated in a number of diseases including Alzheimer's Disease and type II diabetes. Despite the fact that many different chemically unrelated proteins form amyloid fibrils, the final fibrillar complexes appear to share similar fundamental structures. The primary objective of the proposed work was to determine the intermolecular organisation of polypeptide in a model amyloid fibril system at high resolution using solid-state NMR techniques.

The most significant achievement of this award was the first determination of the 3D structure of an amyloid fibril using a simplified model system. We also extended this approach to a larger and far more challenging system, making the first steps towards determining its structure at atomic resolution.

Since all amyloid fibril structures share a common structure, whether derived from model polypeptide systems or disease-related proteins, our findings provide insight that are of relevance to medicine and to the pharmaceutical industry.
Exploitation Route Our findings present the first atomistic structure of a polypeptide in an amyloid fibre. This can be used to design small molecule inhibitors to arrest protein self-assembly, of relevance to diseases of ageing such as Alzheimer's Disease and Parkinson's Disease.

We also presented advanced methods for the determination of protein structure using MAS solid-state-NMR spectroscopy, which have applications towards a wide variety of protein and polypeptide systems.
Sectors Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology

 
Description Our published findings have been cited by those seeking small molecule inhibitors for protein aggregation diseases. Others have applied the methods we describe in a number of our publications to advance the use of solid-state NMR for the determination of protein structures. A further use of our research has been in the fields of biomaterials and nanotechnology. Protein fibres represent robust scaffolds with silk-like properties, with applications as cell scaffolds or slow-release formulations. A number of research groups worldwide have exploited our findings to extend our understanding of the mechanical properties of such materials.
First Year Of Impact 2009
Sector Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology